Search Results - "Peceny, R"

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome by Schnittger, S, Eder, C, Jeromin, S, Alpermann, T, Fasan, A, Grossmann, V, Kohlmann, A, Illig, T, Klopp, N, Wichmann, H-E, Kreuzer, K-A, Schmid, C, Staib, P, Peceny, R, Schmitz, N, Kern, W, Haferlach, C, Haferlach, T

“…We aimed at evaluating ASXL1 mut in 740 AML with intermediate risk karyotype for frequency, association with other mutations and impact on outcome. Five…”
Get full text

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia by Müller-Tidow, C, Tschanter, P, Röllig, C, Thiede, C, Koschmieder, A, Stelljes, M, Koschmieder, S, Dugas, M, Gerss, J, Butterfaß-Bahloul, T, Wagner, R, Eveslage, M, Thiem, U, Krause, S W, Kaiser, U, Kunzmann, V, Steffen, B, Noppeney, R, Herr, W, Baldus, C D, Schmitz, N, Götze, K, Reichle, A, Kaufmann, M, Neubauer, A, Schäfer-Eckart, K, Hänel, M, Peceny, R, Frickhofen, N, Kiehl, M, Giagounidis, A, Görner, M, Repp, R, Link, H, Kiani, A, Naumann, R, Brümmendorf, T H, Serve, H, Ehninger, G, Berdel, W E, Krug, U

“…DNA methylation changes are a constant feature of acute myeloid leukemia. Hypomethylating drugs such as azacitidine are active in acute myeloid leukemia (AML)…”
Get full text

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation by TRENSCHEL, R, DITSCHKOWSKI, M, BEELEN, D. W, ELMAAGACLI, A. H, KOLDEHOFF, M, OTTINGER, H, STECKEL, N, HLINKA, M, PECENY, R, RATH, P-M, DERMOUMI, H

“…Caspofungin (CAS) is the first of a new class of antifungal agents, the echinocandins, that interfere with fungal cell wall synthesis by inhibition of glucan…”
Get full text

Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia by KOLDEHOFF, M, BEELEN, D. W, TRENSCHEL, R, STECKEL, N. K, PECENY, R, DITSCHKOWSKI, M, OTTINGER, H, ELMAAGACLI, A. H

“…Atypical chronic myeloid leukemia (aCML) occurs rarely and is associated with a poor prognosis when treated with conventional chemotherapy. We evaluated the…”
Get full text

Impact of HLA-A, B, C allele mismatches on outcome after unrelated blood stem cell transplantation in whites by OTTINGER, H. D, FERENCIK, S, BEELEN, D. W, LINDEMANN, M, PECENY, R, ELMAAGACLI, A. H, GROSSE-WILDE, H

“…At our institution the selection of unrelated donors for hematopoietic stem cell transplantation (HSCT) relies on low resolution human leukocyte antigen…”
Get full text

Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases by KREMENS, B, BASU, O, PECENY, R, GROSSE-WILDE, H, SCHAEFER, U. W, HAVERS, W

“…Allogeneic peripheral stem cell transplantation in six children with non-malignant hematologic or metabolic diseases which are eventually fatal was carried out…”
Get full text

Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia : results of a phase II study by BEELEN, D. W, PECENY, R, ELMAAGACLI, A, OTTINGER, H, KUMMER, G, OPALKA, B, SEEBER, S, SCHAEFER, U. W

“…The feasibility of transplantation using highly purified G-CSF-mobilized peripheral blood CD34+ cells from HLA-identical sibling donors without prophylactic…”
Get full text

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias by Beelen, Dietrich W., Ottinger, Hellmut D., Ferencik, Stanislav, Elmaagacli, Ahmet H., Peceny, Rudolf, Trenschel, Rudolf, Grosse-Wilde, Hans

“…It remains controversial whether alloreactive donor-derived natural killer (NK) cells display graft-versus-leukemia reactions after unmodified allogeneic…”
Get full text

Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation by ELMAAGACLI, Ahmet H, KOLDEHOFF, Michael, GROSSE-WILDE, Hans, BEELEN, Dietrich W, HINDAHL, Heidrun, STECKEL, Nina K, TRENSCHEL, Rudolf, PECENY, Rudolf, OTTINGER, Hellmut, RATH, Peter-Michael, ROSS, Rudolf Stefan, ROGGENDORF, Michael

“…NOD2 and TLR-4 genes belong to the innate immune system that detects invading pathogens through several pattern-recognition receptors. Here we analyzed 403…”
Get full text

T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors by Ditschkowski, Markus, Elmaagacli, Ahmet H, Trenschel, Rudolf, Peceny, Rudolf, Koldehoff, Michael, Schulte, Claudia, Beelen, Dietrich W

“…From the Department of bone marrow transplantation, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany. Correspondence:Markus Ditschkowski,…”
Get full text

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors by Ottinger, Hellmut D., Ferencik, Stanislav, Beelen, Dietrich W., Lindemann, Monika, Peceny, Rudolf, Elmaagacli, Ahmed H., Hüsing, Johannes, Grosse-Wilde, Hans

“…Allogeneic hematopoietic stem cell transplantation (HSCT) is a proven curative therapy for many hematologic malignancies. HSCT from HLA-identical sibling…”
Get full text

Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia by Elmaagacli, Ahmet H., Peceny, Rudolf, Steckel, Nina, Trenschel, Rudolf, Ottinger, Hellmut, Grosse-Wilde, Hans, Schaefer, Ulrich W., Beelen, Dietrich W.

“…Outcomes of highly purified CD34+ peripheral blood stem cell transplantation (PBSCT) for chronic phase chronic myeloid leukemia (CML) (n = 32) were compared…”
Get full text

Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor by ELMAAGACLI, Ahmet H, OTTINGER, Hellmut, KOLDEHOFF, Michael, PECENY, Rudolf, STECKEL, Nina K, TRENSCHEL, Rudolf, BIERSACK, Harald, GROSSE-WILDE, Hans, BEELEN, Dietrich W

“…To examine how killer-cell immunoglobulin-like receptor (KIR) ligand incompatibilities effect molecular relapse (MR), we compared the occurrence of…”
Get full text

WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells by Elmaagacli, AH, Koldehoff, M, Peceny, R, Klein-Hitpass, L, Ottinger, H, Beelen, DW, Opalka, B

“…Department of Bone Marrow Transplantation, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany. ahmet.elmaagacli@uni-essen.de BACKGROUND AND…”
Get full text

Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia by Elmaagacli, Ahmet H., Basoglu, Semiha, Peceny, Rudolf, Trenschel, Rudolf, Ottinger, Hellmut, Lollert, Andre, Runde, Volker, Grosse-Wilde, Hans, Beelen, Dietrich W., Schaefer, Ulrich W.

“…Outcomes after peripheral blood stem cell transplantation (PBSCT) for chronic phase chronic myeloid leukemia (n = 37) were compared with outcomes after bone…”
Get full text

G-CSF-induced alteration of in-vitro reactions towards mitogens, recall and alloantigens in stem cell donors is predictive for the occurrence of GVHD in recipients by Lindemann, M, Ottinger, H D, Peceny, R, Beelen, D W, Grosse-Wilde, H

“…In the hematopoietic stem cell transplantation (HSCT) setting, granulocyte colony-stimulating factor (G-CSF) administration can reduce donor cell reactivity…”
Get full text

G-CSF-induced alteration of in vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GVHD in recipients by Lindemann, Monika, Grosse-Wilde, Hans, Ottinger, Hellmut D, Peceny, Rudolf, Beelen, Dietrich W

Get full text

Allogeneic CD34 super(+)-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases by Kremens, B, Basu, O, Peceny, R, Grosse-Wilde, H, Schaefer, U W, Havers, W

“…Allogeneic peripheral stem cell transplantation in six children with non-malignant hematologic or metabolic diseases which are eventually fatal was carried out…”
Get full text

Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34 super(+) cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study by Beelen, D W, Peceny, R, Elmaagacli, A, Ottinger, H, Kummer, G, Opalka, B, Seeber, S, Schaefer, U W

“…The feasibility of transplantation using highly purified G-CSF-mobilized peripheral blood CD34 super(+) cells from HLA-identical sibling donors without…”
Get full text

Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination by TRENSCHEL, R, PECENY, R, RUNDE, V, ELMAAGACLI, A, DERMOUMI, H, HEINTSCHEL VON HEINEGG, E, MÜLLER, K-D, SCHAEFER, U. W, BEELEN, D. W

“…Invasive fungal infections (IFI) are increasingly diagnosed in patients undergoing allogeneic BMT. We have previously shown that the addition of metronidazole…”
Get full text